ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2018 American Transplant Congress

    Survival Benefit of Partial Grafts in Pediatric Candidates with Acute Liver Failure Awaiting Liver Transplantation: SRTR Analysis over 26 Years

    D. Firl, K. Sasaki, C. Quintini, B. Eghtesad, C. Miller, K. Hashimoto.

    CCF, Cleveland.

    Objective: Pediatric fulminant hepatic failure (PFHF) is a devastating condition which portends a poor prognosis without liver transplantation (LT). In comparison to adult candidates, there…
  • 2018 American Transplant Congress

    Evaluating Center Performance beyond Patient and Graft Survival

    S. Asrani, G. Saracino, R. Bahirwani, G. McKenna, G. Klintmalm, J. Trotter.

    Baylor University Medical Center, Dallas, TX.

    Introduction: LT centers are judged by patient survival at 1-yr post LT; however risk incurred on the waitlist or center specific practices post LT are…
  • 2018 American Transplant Congress

    Development of Post-Transplant DSA Following Immunosuppression Minimization/Withdrawal in Liver Transplant Recipients

    V. Jucaud,1 A. Shaked,2 M. DesMarais,3 P. Sayre,3 M. Everly.1

    1Terasaki Research Institute, Los Angeles; 2University of Pennsylvania, Philadelphia, PA; 3Immune Tolerance Network, Seattle, WA.

    Despite the allograft-risk associated with DSA, the development of post-transplant HLA donor-specific antibody (DSA) is not well described in liver transplant (LT) patients undergoing immunosuppression…
  • 2018 American Transplant Congress

    Staged Biliary Reconstruction after Liver Transplantation Reduces Post-Transplant Biliary Complications in High-Acuity Patients

    T. Pearson, M. Zimmerman, J. Kim, P. Palines, M. Wong, C. Erickson, J. Hong.

    Medical College of Wisconsin, Milwaukee, WI.

    Biliary complications (BC) after liver transplantation (LT) are strongly associated with inferior patient outcomes and increased healthcare cost. High-acuity LT patients are at increased risk…
  • 2018 American Transplant Congress

    Large Decrease in Liver Waiting List Dropout Rate for MELD > 14

    D. Schladt,1 J. Pyke,1 A. Israni,1 W. Kim,2 J. Lake,3 J. Snyder.1

    1SRTR, Minneapolis; 2Stanford University, Stanford; 3Univ of Minnesota, Minneapolis.

    Median MELD at transplant has increased steadily over the past 10 years. One possible mechanism is decreased waitlist dropout rates, particularly among liver candidates with…
  • 2018 American Transplant Congress

    Kidney Donor Profile Index (KDPI) is Not Inferior to Liver Donor Risk Index (LDRI) in Predicting Long-Term Liver Graft Survival

    U. Scheuermann, K. Freischlag, Q. Gao, J. Yerxa, B. Ezekian, R. Davis, P. Schroder, A. Barbas.

    Surgery, Duke University, Durham, NC.

    Background: The primary aim of this study was to assess liver graft survival as a function of Kidney Donor Profile Index (KDPI), and compare the…
  • 2018 American Transplant Congress

    Radiation Exposure to the Transplant Surgeon: A Case Study of Recent Yttrium-90 Treatment in an Explanted Liver

    M. Decoteau,1 P. Lewis,1 S. Steuterman,2 R. Schaffer,1 J. Fisher,1 J. Case,1 C. Marsh.1

    1Organ Transplantation, Scripps Green Hospital, La Jolla, CA; 2Medical Physics & Radiation Safety, Scripps Green Hospital, La Jolla, CA.

    BACKGROUND: Yttrium-90 (Y-90) radioembolization for the treatment of hepatocellular carcinoma can present safety challenges to the surgeon when transplanting a recently treated Y-90 patient. To…
  • 2018 American Transplant Congress

    The Effect of Pre-Transplant Insomnia and Post-Transplant Insomnia on Survival among Solid Organ Recipients

    K-.F. Lee,2 Y. Tsai,1 C. Lin,1 C-.B. Hsieh,3,5 S. Wu,4 T. Chen,5 Y-.C. Lin,1 W-.H. Lee,6,7 F. Lin,8 C. Tsai.1,9,10

    1Cardiovascular Surgery, Tri-Service General Hospital, Taipei, Taiwan; 2Biobank Management Center, Tri-Service General Hospital, Taipei, Taiwan; 3General Surgery, Hualien Armed Forces General Hospital, Hualien County, Taiwan; 4Urology, Tri-Service General Hospital, Taipei, Taiwan; 5General Surgery, Tri-Service General Hospital, Taipei, Taiwan; 6Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 7Pathology, Taipei Medical University-Shuang Ho Hospital, New Taipei, Taiwan; 8Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 9Cardiovascular Surgery, Taoyuan Armed Forces General Hospital, Taoyuan, Taiwan; 10Graduate Institute of Pharmacology, National Defense Medical Center, Taipei, Taiwan.

    BackgroundBecause studies about insomnia among organ recipients were scarce, we used National Health Insurance Research Database (NHIRD) between 2001 and 2012 to understand how pre-transplant…
  • 2018 American Transplant Congress

    Cannabis Use in Liver Transplant Recipients: A Single Center Experience

    J. Lee, M. Valadez, E. Moreno, D. Markovic, V. Agopian, J. DiNorcia, H. Yersiz, D. Farmer, R. Busuttil, F. Kaldas.

    Division of Liver and Pancreas Transplant, David Geffen School of Medicine, LA, CA.

    Introduction: Cannabis is one of the most commonly used illicit drugs worldwide. In the US, cannabis has gained wider social and political acceptance. Liver transplant…
  • 2018 American Transplant Congress

    Portal Vein Flow as an Indicator of Liver Transplantation for Acute Liver Failure

    C-.H. Cheng,1 C. Lee,2 Y-.C. Wang,1 T-.H. Wu,1 C-.F. Lee,1 T-.J. Wu,1 H. Chou,1 K-.M. Chan,1 W-.C. Lee.1

    1Division of Liver and Transplantation Surgery, Department of General Surgery, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan; 2Department of Hepatology, Chang-Gung Memorial Hospital, Chang-Gung University College of Medicine, Taoyuan, Taiwan.

    Background: Liver transplantation is the most effective treatment for acute liver failure. Timing of liver transplantation is important to rescue the dying patients. This study…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences